No products in the cart.
Roll over image to zoom in
MYCOPHEN 500MG TABLET
₹415.00₹691.84 (-40%)
Mycophen 500mg Tablet is an immunosuppressant with an active ingredient named Mycophenolate mofetil. It falls under the inosine-monophosphate dehydrogenase (IMPDH) inhibitor class. It is prescribed to avoid organ rejection in people who have had one of their organs (such as heart, kidney transplantation, or liver). It is usually defined as part of a combination treatment that includes other immunosuppressive medications.
The use of this drug is not recommended during pregnancy due to the possibility of miscarriage and congenital disabilities. It should not be used during pregnancy unless there are other alternatives and the advantages outweigh the risks. Women who are pregnant are advised to utilize an effective contraceptive tablet to avoid the possibility of pregnancy. Live vaccines shouldn’t be administered if a patient takes Mycophen 500 mg Tablet due to the reduced effectiveness and risk of contracting infection. Patients taking this medication are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures the drug is entirely cleared out of the body before blood donation.
It is recommended not to use this medication if you are allergic to the drug or other components. Inform your physician about heart or liver problems before starting the treatment. Because this drug weakens the body’s immune system, it could increase the risk of developing skin cancer. Patients must know how to minimize their exposure to sun and UV (UV) radiation. Contact your doctor right away if you experience any bleeding on your skin or fever. Or any other unidentified fatigue, dizziness, discoloration of the skin or eyes, visual impairment, decreased urine output, or seizures following taking the medication. Mycophen 500 mg Tablet is an immunosuppressive drug. It could affect a baby’s developing immune system and should not be used while breastfeeding. In certain instances, alternative medicines with an improved safety profile while breastfeeding could be thought of as.